What was Braskem's Q2 2026 consolidated Recurring EBITDA, and what drove this performance?

Braskem S.A. reported a consolidated Recurring EBITDA of US$1.043 billion for Q2 2026, driven by wider chemical and petrochemical spreads, particularly in Brazil/South America.

Why have Braskem's credit ratings been downgraded to C/D, and what restructuring actions is the company taking?

Despite improved operating results and cash flow generation, Braskem remains under significant financial stress due to gross debt of US$10.3 billion and corporate leverage of 6.74x, leading Fitch and S&P to downgrade its credit ratings to C/D; the company is pursuing a capital structure restructuring supported by Brazilian Emergency Injunctive Relief and a U.S. Chapter 15 process to temporarily suspend creditor enforcement actions.

Braskem (BAK) Posts $1.0B EBITDA as Ratings Fall to C/D and Talks on Debt

Aug 14, 2026

Braskem reported a $1.04 billion Q2 EBITDA driven by favorable chemical spreads, yet high leverage prompted credit downgrades to C/D. The company is now pursuing debt restructuring via Brazilian relief and U.S. Chapter 15 proceedings.

Stock Titan

2026-04-02

Braskem (NYSE: BAK) weighs creditor protection options while reviewing capital structure

2026-04-04

Pomerantz Law Firm Investigates Braskem S.A. Over Investor Claims

2026-04-08

Braskem Reviews Creditor Options as Shareholders Weigh São Paulo Move

2026-04-08

Braskem Clarifies Capital Structure Review and Plans Shareholder Vote on Legal Domicile Change

2026-04-09

Braskem (BAK) Outlines Braskem Idesa Missed Interest Payments and Debt Talks